Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled time : 13:30 save search
Lilly Completes Acquisition of POINT Biopharma
Published: 2023-12-27 (Crawled : 13:30) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.03%
H: 2.31%
C: 1.93%
biopharma acquisition
Rigel Announces Publication of Data from Phase 2 Clinical Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia in the American Journal of Hematology
Published: 2022-03-08 (Crawled : 13:30) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
RIGL | $1.06 -4.51% -4.72% 1.2M
|
Health Technology
|
| O: -1.78%
H: 8.93%
C: 3.63%
america treatment ema phase 2 anemia antibody
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
CNTA | $10.57 -1.95% -1.99% 110K
|
Manufacturing
|
| O: -8.81%
H: 10.7%
C: -3.99%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
als
Clinical Catch-Up: Covaxin, Celyad Hold, CRISPR's Next Step
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 7.22%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
DRRX | $0.9042 2.98% 2.9% 120K
|
Health Technology
|
| O: -1.84%
H: 1.67%
C: -7.94%
xin crispr cel
Veru to Present at the Oppenheimer 32nd Annual Healthcare Conference on March 15-17, 2022
Published: 2022-03-01 (Crawled : 13:30) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: -2.78%
H: 1.25%
C: -0.54%
health thc conference
Benign Prostatic Hyperplasia Therapeutics Market to Reach $9.39 Bn, Globally, by 2030 at 5.0% CAGR: Allied Market Research
Published: 2022-02-22 (Crawled : 13:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.57%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 1.84%
H: 0.49%
C: 0.09%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -0.61%
H: 1.05%
C: -0.86%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.93%
H: 0.77%
C: 0.12%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: 0.83%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
research therapeutics
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
Published: 2022-02-11 (Crawled : 13:30) - globenewswire.com
DERM | $3.54 -8.29% -9.04% 190K
|
|
| O: 0.76%
H: 3.98%
C: -0.95%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
qbrexza approval corporation one milestone
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG A | $135.11 0.11% -0.82% 2.3M
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $5.36 -1.83% -1.87% 840K
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
PHAT | $9.5 -3.06% -3.16% 420K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
space spac
Bluestar Genomics Appoints David Mullarkey Chief Executive Officer
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.81%
H: 0.0%
C: 0.0%
health genomics genomic thc conference j.p. morgan healthcare conference
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
Published: 2021-12-30 (Crawled : 13:30) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.28%
H: 0.52%
C: -0.69%
BYSI | $1.81 -2.16% -2.21% 56K
|
Health Technology
|
| O: -2.52%
H: 10.33%
C: 9.15%
financial results results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.